Targeting PP2A to overcome enzalutamide resistance in AR+ breast tumors

Ion Cristóbal, Blanca Torrejón, Manuel Pedregal, Federico Rojo, Jesús García-Foncillas
2017 Endocrine-Related Cancer  
doi:10.1530/erc-16-0444 pmid:27765801 fatcat:xj6r2zpvqzbutjxx33u7iwcsoi